Not applicableLooking for participantsNCT07124000What this trial is testingDESTINY-PANTUMOUR04Who this might be right forAdenocarcinoma (NOS)Anal CancerBladder Cancer+24 more AstraZeneca 100
Early research (Phase 1)Ended earlyNCT06580938What this trial is testingLearn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With CancerWho this might be right forNon Small Cell Lung CancerBladder CancerRenal Cell Carcinoma+3 more Pfizer 4
Testing effectiveness (Phase 2)Study completedNCT03693612What this trial is testingGSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid TumorsWho this might be right forNeoplasms GlaxoSmithKline 26
Testing effectiveness (Phase 2)Study completedNCT00002914What this trial is testingPiritrexim in Treating Patients With Advanced Cancer of the Urinary TractWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer Eastern Cooperative Oncology Group 40
Not applicableUnknownNCT04718948What this trial is testingMultimodal Spectroscopy to Detect Urothelial Cancer in UrineWho this might be right forUrothelial CarcinomaUrinary Bladder CancerUrinary Tract Cancer University of Florence 500
Early research (Phase 1)Active Not RecruitingNCT04459273What this trial is testingProspective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various CancersWho this might be right forBladder CarcinomaCervical CarcinomaCholangiocarcinoma+13 more Jonsson Comprehensive Cancer Center 26
Early research (Phase 1)Study completedNCT03617003What this trial is testingTreatment of Tumors in the Urinary Collecting System of the Kidney or Ureter Using a Light Activated Drug (WST11)Who this might be right forUpper Tract Urothelial Carcinoma Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT07186842What this trial is testingA Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9Who this might be right forAdvanced Solid Cancers BioNTech SE 245
Early research (Phase 1)Not Yet RecruitingNCT07664397What this trial is testingImaging Study of [89Zr]DFO-YS5 for Cancer DetectionWho this might be right forBladder CancerNerve Sheath TumorNerve Sheath Tumors+9 more Robert Flavell, MD, PhD 40
Testing effectiveness (Phase 2)Study completedNCT00003103What this trial is testingChemotherapy in Treating Patients With Solid TumorsWho this might be right forBladder CancerBreast CancerColorectal Cancer+7 more Memorial Sloan Kettering Cancer Center 57
Testing effectiveness (Phase 2)Looking for participantsNCT03866382What this trial is testingTesting the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary TumorsWho this might be right forBladder AdenocarcinomaBladder Clear Cell AdenocarcinomaBladder Mixed Adenocarcinoma+42 more National Cancer Institute (NCI) 314
Not applicableActive Not RecruitingNCT05219734What this trial is testingMRD Assay Evaluates Recurrence and Response Via a Tumor Informed AssessmentWho this might be right forCancerSolid TumorNon Small Cell Lung Cancer+2 more Invitae Corporation 400
Testing effectiveness (Phase 2)Looking for participantsNCT06161532What this trial is testingSacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...Who this might be right forSmall Cell Carcinoma of the BladderSmall Cell Carcinoma of the Urinary TractSquamous Cell Carcinoma of the Bladder+5 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT03827837What this trial is testingFamitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological TumorsWho this might be right forRenal Cell CarcinomaUrothelial CarcinomaCervical Cancer+2 more Jiangsu HengRui Medicine Co., Ltd. 265
Not applicableStudy completedNCT01170299What this trial is testingLow-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal CancerWho this might be right forAnal CancerBladder CancerCervical Cancer+6 more Royal Marsden NHS Foundation Trust 177
Testing effectiveness (Phase 2)Ended earlyNCT00087295What this trial is testingS0400, FR901228 in Treating Patients With Advanced Cancer of the UrotheliumWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer SWOG Cancer Research Network 6
Not applicableLooking for participantsNCT07494864What this trial is testingEffects of Microbiological and Immunological Factors on the Lower Urinary TractWho this might be right forAsymptomatic Bacteriuria in Subjects Not Requiring Assisted Bladder EmptyingAsymptomatic Bacteriuria in Subjects Relying on Some Type of CatheterRecurrent Non-catheter Associated UTIs+5 more University of Zurich 800
Post-approval studies (Phase 4)Looking for participantsNCT05962541What this trial is testingVesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs)Who this might be right forNon-muscle-invasive Bladder CancerNon-Muscle Invasive Bladder Urothelial CarcinomaHigh Risk Non-Muscle Invasive Bladder Urothelial Carcinoma University of Roma La Sapienza 327
Early research (Phase 1)Study completedNCT00413322What this trial is testingStudy of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid TumorsWho this might be right forTumor Valerio Therapeutics 35
Early research (Phase 1)Study completedNCT05858736What this trial is testingSafety, PK and Efficacy of AI-061 in Advanced Solid TumorsWho this might be right forMelanomaNon Small Cell Lung CancerHead and Neck Squamous Cell Carcinoma+14 more OncoC4, Inc. 18